The Triangle’s two newest publicly traded companies – PRA Health Sciences and INC Research – are on the verge of issuing their first quarterly results since their successful initial public offerings.
First up is PRA, which is scheduled to release its fourth-quarter earnings after the markets close on Wednesday. Company executives will follow up with a discussion about the results with a conference call and webcast scheduled for 9 a.m. Thursday.
INC Research intends to release its fourth-quarter results the morning of Tuesday, Feb. 24, prior to a 9 a.m. conference call and webcast to discuss the results.
Both PRA and INC are Raleigh-based contract research organizations, or CROs, that went public in November. CROs help pharmaceutical and biotechnology companies conduct clinical trials of experimental drugs and analyze the results.
Never miss a local story.
PRA and INC also rank among the world’s largest CROs. The Triangle has more CRO companies and CRO workers than anywhere else.